Anemia in Kawasaki Disease

Ying Hsien Huang; Ho Chang Kuo

doi:10.1007/978-981-19-2944-1_15

Anemia in Kawasaki Disease

Ying Hsien Huang, Ho Chang Kuo^*

^*Corresponding author for this work

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Kawasaki disease (KD) is the most common acute coronary vasculitis syndrome that mainly affects genetically susceptible kids under 5 years of age. Aside from the standard diagnostic five criteria, patients with KD may also experience a variety of nonspecific clinical symptoms and signs. Anemia is the most common clinical feature in KD patients. In 2001, the scientists have the discovery of a liver-derived peptide hormone named as hepcidin began revolutionizing the understanding of anemia’s relation to a number of inflammatory diseases, including KD. This chapter focuses on hepcidin-induced iron deficiency’s relation to transient hyposideremia, anemia, and disease outcomes in KD patients, and goes on to suggest possible routes of KD study.

Original language	English
Title of host publication	Kawasaki Disease
Publisher	Springer Nature
Pages	147-153
Number of pages	7
ISBN (Electronic)	9789811929441
ISBN (Print)	9789811929434
DOIs	https://doi.org/10.1007/978-981-19-2944-1_15
State	Published - 01 01 2022

Bibliographical note

Publisher Copyright:
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.

Keywords

Anemia
HAMP
Hepcidin
Iron
Kawasaki disease

Access to Document

10.1007/978-981-19-2944-1_15

Cite this

@inbook{256d35b969c94048ba454a57f89743af,

title = "Anemia in Kawasaki Disease",

abstract = "Kawasaki disease (KD) is the most common acute coronary vasculitis syndrome that mainly affects genetically susceptible kids under 5 years of age. Aside from the standard diagnostic five criteria, patients with KD may also experience a variety of nonspecific clinical symptoms and signs. Anemia is the most common clinical feature in KD patients. In 2001, the scientists have the discovery of a liver-derived peptide hormone named as hepcidin began revolutionizing the understanding of anemia{\textquoteright}s relation to a number of inflammatory diseases, including KD. This chapter focuses on hepcidin-induced iron deficiency{\textquoteright}s relation to transient hyposideremia, anemia, and disease outcomes in KD patients, and goes on to suggest possible routes of KD study.",

keywords = "Anemia, HAMP, Hepcidin, Iron, Kawasaki disease",

author = "Huang, {Ying Hsien} and Kuo, {Ho Chang}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-981-19-2944-1_15",

language = "英语",

isbn = "9789811929434",

pages = "147--153",

booktitle = "Kawasaki Disease",

publisher = "Springer Nature",

}

TY - CHAP

T1 - Anemia in Kawasaki Disease

AU - Huang, Ying Hsien

AU - Kuo, Ho Chang

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Kawasaki disease (KD) is the most common acute coronary vasculitis syndrome that mainly affects genetically susceptible kids under 5 years of age. Aside from the standard diagnostic five criteria, patients with KD may also experience a variety of nonspecific clinical symptoms and signs. Anemia is the most common clinical feature in KD patients. In 2001, the scientists have the discovery of a liver-derived peptide hormone named as hepcidin began revolutionizing the understanding of anemia’s relation to a number of inflammatory diseases, including KD. This chapter focuses on hepcidin-induced iron deficiency’s relation to transient hyposideremia, anemia, and disease outcomes in KD patients, and goes on to suggest possible routes of KD study.

AB - Kawasaki disease (KD) is the most common acute coronary vasculitis syndrome that mainly affects genetically susceptible kids under 5 years of age. Aside from the standard diagnostic five criteria, patients with KD may also experience a variety of nonspecific clinical symptoms and signs. Anemia is the most common clinical feature in KD patients. In 2001, the scientists have the discovery of a liver-derived peptide hormone named as hepcidin began revolutionizing the understanding of anemia’s relation to a number of inflammatory diseases, including KD. This chapter focuses on hepcidin-induced iron deficiency’s relation to transient hyposideremia, anemia, and disease outcomes in KD patients, and goes on to suggest possible routes of KD study.

KW - Anemia

KW - HAMP

KW - Hepcidin

KW - Iron

KW - Kawasaki disease

UR - http://www.scopus.com/inward/record.url?scp=85169388713&partnerID=8YFLogxK

U2 - 10.1007/978-981-19-2944-1_15

DO - 10.1007/978-981-19-2944-1_15

M3 - 章节

AN - SCOPUS:85169388713

SN - 9789811929434

SP - 147

EP - 153

BT - Kawasaki Disease

PB - Springer Nature

ER -

Anemia in Kawasaki Disease

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this